Cargando…

Circulating tumor DNA: Where are we now? A mini review of the literature

For many years tissue biopsy has been the primary procedure to establish cancer diagnosis and determine further treatment and prognosis. However, this method has multiple drawbacks, including, to mention some, being an invasive procedure carrying significant risk for fragile patients and allowing on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galarza Fortuna, Gliceida Maria, Dvir, Kathrin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522544/ https://www.ncbi.nlm.nih.gov/pubmed/33033694 http://dx.doi.org/10.5306/wjco.v11.i9.723

Ejemplares similares

Angiogenesis inhibitors in clinical development; where are we now and where are we going?
por: Eskens, F A L M
Publicado: (2004)

Role of endoscopic ultrasound in vascular interventions: Where are we now?
por: Fugazza, Alessandro, et al.
Publicado: (2022)

Esophagogastric junction outflow obstruction: Where are we now in diagnosis and management?
por: Samo, Salih, et al.
Publicado: (2019)

Viscoelastic tests in liver disease: where do we stand now?
por: Buliarca, Alina, et al.
Publicado: (2021)

Delayed Presentation of Thymoma-Related Aplastic Anemia: An Unusual Presentation of a Rare Complication
por: Dvir, Kathrin, et al.
Publicado: (2019)

Second-line rescue treatment of Helicobacter pylori infection: Where are we now?
por: Lin, Te-Fu, et al.
Publicado: (2018)

Primary Central Nervous System Lymphoma in an Immunocompetent Patient Presenting as Multiple Cerebellar Lesions: A Case Report and Review of Literature
por: Galarza Fortuna, Gliceida M., et al.
Publicado: (2019)

Antiglutamatergic agents for obsessive-compulsive disorder: Where are we now and what are possible future prospects?
por: Maraone, Annalisa, et al.
Publicado: (2021)

Apical polarity in three-dimensional culture systems: where to now?
por: Inman, Jamie L, et al.
Publicado: (2010)

Lung Adenocarcinoma Presenting as Multiple Thromboembolic Events: A Case Report and Review of the Literature
por: Galarza Fortuna, Gliceida M., et al.
Publicado: (2020)

Papillary Thyroid Carcinoma With Cystic Changes in a Patient With Prior History of Toxic Nodule
por: Fortuna, Gliceida Maria Galarza, et al.
Publicado: (2020)

Linkage of microbiota and osteoporosis: A mini literature review
por: Yatsonsky II, David, et al.
Publicado: (2019)

Liver transplantation for hepatocellular carcinoma: Where do we stand?
por: Santopaolo, Francesco, et al.
Publicado: (2019)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Where are we now?
Publicado: (1977)

Sessile serrated adenoma/polyps: Where are we at in 2016?
por: Singh, Rajvinder, et al.
Publicado: (2016)

Hepatitis C virus micro-elimination: Where do we stand?
por: Mangia, Alessandra, et al.
Publicado: (2021)

Artificial intelligence and inflammatory bowel disease: Where are we going?
por: Da Rio, Leonardo, et al.
Publicado: (2023)

Should we initiate vasopressors earlier in patients with septic shock: A mini systemic review
por: Zhou, Hang-Xiang, et al.
Publicado: (2023)

Colorectal cancer, screening and primary care: A mini literature review
por: Hadjipetrou, Athanasios, et al.
Publicado: (2017)

Defining the Pseudomonas Genus: Where Do We Draw the Line with Azotobacter?
por: Özen, Asli I., et al.
Publicado: (2011)

Where does chemotherapy stands in the treatment of ampullary carcinoma? A review of literature
por: Ghosn, Marwan, et al.
Publicado: (2016)

NIPPV: Where Are We Now?
por: Fakharian, Atefeh, et al.
Publicado: (2013)

Onchodermatitis: Where Are We Now?
por: Murdoch, Michele E.
Publicado: (2018)

Where does DNA replication start in archaea?
por: Vas, Amit, et al.
Publicado: (2000)

Role of endoscopic ultrasound in liver disease: Where do we stand in 2017?
por: Saraireh, Hamzeh A, et al.
Publicado: (2017)

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Intrahepatic Cholangiocarcinoma—Where Are We Now and Where Are We Going to?
por: Wasilewicz, Michał P., et al.
Publicado: (2023)

Circulating tumor DNA for diagnosis, prognosis and treatment of gastrointestinal malignancies
por: Kirchweger, Patrick, et al.
Publicado: (2022)

Reactivation of Epstein–Barr Virus Presenting as Massive Splenomegaly after Initiation of Golimumab Treatment
por: Febres-Aldana, Anthony J., et al.
Publicado: (2020)

A Comprehensive Review on Bariatric Endoscopy: Where We Are Now and Where We Are Going
por: Mauro, Aurelio, et al.
Publicado: (2023)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

Platelet-Rich Plasma: Where Are We Now and Where Are We Going?
por: Cole, Brian J., et al.
Publicado: (2010)

Aging with Down Syndrome—Where Are We Now and Where Are We Going?
por: Alldred, Melissa J., et al.
Publicado: (2021)

Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?
por: Jang, Albert, et al.
Publicado: (2021)

Ten Years for GHSP: Where Are We Now? Where Will We Go?
por: Bhutta, Zulfiqar A., et al.
Publicado: (2023)

Targeting therapy in pemphigus: Where are we now and where are we going?
por: Abulikemu, Kailibinuer, et al.
Publicado: (2023)

CAR-T cell therapy: Where are we now, and where are we heading?
por: Wang, Jia-Yi, et al.
Publicado: (2023)

Screening and surveillance methods for dysplasia in inflammatory bowel disease patients: Where do we stand?
por: Galanopoulos, Michail, et al.
Publicado: (2018)

Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand?
por: Mikolasevic, Ivana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d77e13u4ndui3r2qg1qb8qb6oa